/CSWYF
CSWYF Stock - China Shineway Pharmaceutical Group Limited
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$1.00+0.00%
+$0.00 (+0.00%) • Dec 19
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.86
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $1.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CSWYF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.99 – $1.01
TARGET (TP)$1.15
STOP LOSS$0.92
RISK/REWARD1:1.7
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.85
52W High$1.00
52W Low$0.93
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $3.78B | $4.52B | $588.09M | $498.18M | $384.87M |
| Gross Profit | $2.83B | $3.39B | $437.40M | $372.50M | $288.08M |
| Gross Margin | 75.0% | 75.1% | 74.4% | 74.8% | 74.9% |
| Operating Income | $842.60M | $975.53M | $106.22M | $82.58M | $61.21M |
| Net Income | $840.05M | $137.16M | $107.59M | $86.03M | $42.76M |
| Net Margin | 22.2% | 3.0% | 18.3% | 17.3% | 11.1% |
| EPS | $1.11 | $0.18 | $0.14 | $0.11 | $0.06 |
Company Overview
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CSWYFBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.11
Q3 2025
EPS Surprise History
Q4 22
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q3 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 26, 2026 | — | — | — | — |
Q3 2025 | Sep 1, 2025 | — | $0.11 | — | — |
Q1 2025 | Mar 26, 2025 | — | $0.11 | — | — |
Q4 2024 | Dec 31, 2024 | — | $1.00 | — | — |
Q3 2024 | Aug 29, 2024 | — | $0.11 | — | — |
Q1 2024 | Mar 28, 2024 | — | — | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.04 | — | — |
Q3 2023 | Aug 30, 2023 | — | $0.09 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.05 | — | — |
Q1 2023 | Mar 30, 2023 | — | — | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.07 | — | — |
Q3 2022 | Aug 30, 2022 | — | $0.07 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.07 | — | — |
Q1 2022 | Mar 29, 2022 | — | — | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.05 | — | — |
Q3 2021 | Aug 31, 2021 | — | $0.06 | — | — |
Q2 2021 | Jun 30, 2021 | — | $0.06 | — | — |
Q1 2021 | Mar 30, 2021 | — | — | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.01 | — | — |
Q2 2020 | Jun 30, 2020 | — | $0.05 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CSWYF
What is CSWYF's current stock price?
China Shineway Pharmaceutical Group Limited (CSWYF) is currently trading at $1.00 per share. The stock has moved +0.00% today.
What is the analyst price target for CSWYF?
No analyst price targets are currently available for this stock.
What sector is China Shineway Pharmaceutical Group Limited in?
China Shineway Pharmaceutical Group Limited operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is CSWYF's market cap?
China Shineway Pharmaceutical Group Limited has a market capitalization of $0.76 billion, making it a small-cap company.
Does CSWYF pay dividends?
No, China Shineway Pharmaceutical Group Limited does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAIHLF
Adcock Ingram Holdings Limited
$3.50
Mkt Cap: $0.6B
CCHWF
Columbia Care Inc.
$0.94
Mkt Cap: $0.5B
EBRCZ
EBR Systems, Inc.
$0.60
Mkt Cap: $0.5B
IVEVF
Inventiva S.A.
$4.44
Mkt Cap: $0.6B
KDGTF
Kindstar Globalgene Technology, Inc.
$0.68
Mkt Cap: $0.7B
KKPCF
Kaken Pharmaceutical Co., Ltd.
$23.65
Mkt Cap: $0.9B
KSRBF
Kossan Rubber Industries Bhd
$0.33
Mkt Cap: $0.8B
LYPHF
Luye Pharma Group Ltd.
$0.39
Mkt Cap: $1.6B
PEXXF
PT Tempo Scan Pacific Tbk
$0.09
Mkt Cap: $0.5B
TRSSF
TerrAscend Corp.
$1.72
Mkt Cap: $0.6B
Explore stocks similar to CSWYF for comparison